Drug Delivery Company Pegs Future On `Pegnology'

Enzon Inc. gains ground in a growing industry with its innovative approach for enhancing the efficacy and durability of medicine Abraham Abuchowski was a Rutgers University biochemistry graduate student in the 1970s when his adviser set him to work on an inert polymer called polyethylene glycol (PEG). Abe Abuchowski, 42, runs his company the way he teaches karate classes. The cofounder and CEO of Enzon Inc. in South Plainfield, N.J., Abuchowski got hooked on the martial art while an undergra

Written byLeah Beth Ward
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share


Enzon Inc. gains ground in a growing industry with its innovative approach for enhancing the efficacy and durability of medicine
Abraham Abuchowski was a Rutgers University biochemistry graduate student in the 1970s when his adviser set him to work on an inert polymer called polyethylene glycol (PEG).

Abe Abuchowski, 42, runs his company the way he teaches karate classes. The cofounder and CEO of Enzon Inc. in South Plainfield, N.J., Abuchowski got hooked on the martial art while an undergraduate at Rutgers University in New Brunswick, N.J., where he pursued his belts with the same vigor as he pursued his B.S. degree in biology and chemistry. Remaining at Rutgers for graduate study in biochemistry, Abuchowski eventually a second-degree black belt taught biochemistry students by day and eager karate disciples by night. Karate classes and a biomedical company may seem worlds apart, but Abuchowski sees an intimate connection. "I use my ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies